CJC-1295 (with DAC) vs Semax

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

CJC-1295 (with DAC)Semax
CategoryPeptidesPeptides
Standard DoseResearch indicates 2 mg administered once weekly via subcutaneous injection.Research indicates 200-600 mcg daily via intranasal administration (0.1% solution, 2-3 drops per nostril).
TimingEvening administration preferred (aligns with natural GH pulsatility). Inject on an empty stomach — food (especially carbohydrates) blunts GH release.Morning and early afternoon dosing (avoid evening — may cause stimulation/insomnia). Intranasal preferred for rapid CNS delivery.
Cycle Duration12-24 week cycles with 4-8 week breaks between cycles.10-14 day cycles with equal rest periods. Some protocols use 3-5 day on / 2 day off patterns.
Evidence Levelmoderate_humanmoderate_human

Mechanism

CJC-1295 with DAC (Drug Affinity Complex) is a synthetic 30-amino acid GHRH analog with four amino acid substitutions rendering it resistant to DPP-IV proteolytic inactivation. The DAC moiety covalently binds to endogenous serum albumin via a disulfide bond after injection, extending half-life to 5.8-8.1 days. It stimulates pulsatile GH release from anterior pituitary somatotrophs through GHRH receptor activation, producing dose-dependent 2-10 fold increases in plasma GH for 6+ days and 1.5-3 fold IGF-1 elevations for 9-11 days per injection.

Standard Dosing

Research indicates 2 mg administered once weekly via subcutaneous injection.

Timing

Evening administration preferred (aligns with natural GH pulsatility). Inject on an empty stomach — food (especially carbohydrates) blunts GH release.

Cycle Duration

12-24 week cycles with 4-8 week breaks between cycles.

Side Effects

  • Water retention
  • Tingling/numbness in extremities
  • Joint pain
  • Increased hunger
  • Injection site reactions
  • Potential insulin resistance with prolonged use

Contraindications

  • Active cancer or history of cancer
  • Diabetic retinopathy
  • Pregnancy and breastfeeding
  • Intracranial hypertension

Best Stacking Partners

IpamorelinGHRP-2GHRP-6
B

Semax

Peptides

Mechanism

Semax (Met-Glu-His-Phe-Pro-Gly-Pro) is a synthetic heptapeptide analog of the ACTH(4-10) fragment that rapidly upregulates brain-derived neurotrophic factor (BDNF) and its signaling receptor TrkB in the hippocampus (1.4-fold BDNF protein increase, 3-fold exon III BDNF mRNA increase). It activates dopaminergic and serotonergic brain systems, enhances neurotrophin gene expression (BDNF, NGF), and modulates intracellular calcium dynamics in brain neurons. Semax lacks ACTH's corticotropic activity, acting purely as a nootropic/neuroprotective agent.

Standard Dosing

Research indicates 200-600 mcg daily via intranasal administration (0.1% solution, 2-3 drops per nostril).

Timing

Morning and early afternoon dosing (avoid evening — may cause stimulation/insomnia). Intranasal preferred for rapid CNS delivery.

Cycle Duration

10-14 day cycles with equal rest periods. Some protocols use 3-5 day on / 2 day off patterns.

Side Effects

  • Nasal irritation (intranasal route)
  • Mild headache
  • Stimulation/insomnia if dosed late
  • Irritability at high doses
  • Hair loss (anecdotal at high doses)

Contraindications

  • Seizure disorders
  • Acute psychosis or mania
  • Pregnancy and breastfeeding
  • Severe hypertension

Best Stacking Partners

SelankP21Noopept

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →